防己諾林堿對三陰性乳腺癌抗腫瘤機制的研究
[Abstract]:[objective] to study the effect of Tetrandrine on the apoptosis of three-negative breast cancer MDA-MB-231 cells, inhibit the expression of PI3K,AKT,mTOR and phosphorylated PI3K,AKT,mTOR in PI3K/AKT/mTOR pathway, and inhibit the growth of tumor-bearing nude mice. To investigate the anti-tumor mechanism of tri-negative breast cancer treated with fanginolinine. [methods] the inhibitory effect of fanginolinine on MDA-MB-231 of tri-negative breast cancer cells was detected by MDA-MB-231, assay in vitro. The effective concentration of Tetrandrine was determined by calculating its IC50,. 6-well plate cell scratch assay was used to detect the inhibition of MDA-MB-231 migration in triple-negative breast cancer cells, and cell flow cytometry was used to detect the effect of fenpentine on the apoptosis of breast cancer cells. Western Blot was used to detect the expression of PI3K,AKT,mTOR and phosphorylated PI3K,AKT,mTOR protein in PI3K/AKT/mTOR pathway, so as to determine the effect of Tetrandrine on the expression of MDA-MB-231 protein in triple-negative breast cancer cells. To investigate the inhibitory effect of Tetrandrine on the growth of tri-negative breast cancer cells in nude mice. [results] the activity of MDA-MB-231 in tri-negative breast cancer cells was inhibited and the IC50 was measured to be 6.25 渭 mol/L;. The results of scratch test showed that Tetrandrine could also inhibit the migration ability of MDA-MB-231 cells, and the inhibitory effect was obvious with the increase of concentration. Flow cytometry showed that Tetrandrine could promote the apoptosis of MDA-MB-231 cells, and the apoptosis rate was positively correlated with the increase of concentration. Western Blot results showed that Tetrandrine could regulate the expression of PI3K,AKT,mTOR and phosphorylated PI3K,AKT,mTOR protein in PI3K/AKT/mTOR signaling pathway, and the expression of PI3K,AKT,mTOR and phosphorylated PI3K,AKT,mTOR protein was affected by the concentration, and the protein expression decreased with the increase of the concentration. The results of tumorigenesis in nude mice showed that Tetrandrine could inhibit the growth of three-negative breast cancer tumor. [conclusion] Tetrandrine can reduce the activity of MDA-MB-231 cells, accelerate cell apoptosis and inhibit cell migration. The expression of non-phosphorylation and phosphorylated PI3K,AKT,mTOR in PI3K/AKT/mTOR signaling pathway was down-regulated, and the growth, proliferation and migration of TNBC cells were inhibited.
【學位授予單位】:青島大學
【學位級別】:碩士
【學位授予年份】:2017
【分類號】:R737.9
【參考文獻】
相關(guān)期刊論文 前10條
1 劉子梅;沈贊;;三陰性乳腺癌靶向治療最新進展[J];中國癌癥雜志;2017年01期
2 何立麗;顧恪波;;半夏提取物抗惡性腫瘤的作用機制[J];中華中醫(yī)藥雜志;2017年02期
3 葉青;江澤飛;;三陰性乳腺癌精準治療的機遇[J];中國腫瘤臨床;2016年24期
4 李晶;黃三錢;歐陽取長;鐘晶敏;劉志紅;曾亮;;三陰性與三陽性乳腺癌定量蛋白質(zhì)組學和生物信息學比較研究[J];中華腫瘤防治雜志;2016年16期
5 雷姍姍;王映;顧曉文;喻宏;范培芝;張志功;張超杰;何杰;謝靖;李洋;;槐耳顆粒在三陰性乳腺癌術(shù)后輔助治療的臨床研究[J];中國普通外科雜志;2016年05期
6 張帆;劉國文;王佑權(quán);黃果;李偉;鄒眾維;;荷人胃癌細胞裸鼠模型的研究進展[J];腫瘤藥學;2016年01期
7 Joycelyn JX Lee;Kiley Loh;Yoon-Sim Yap;;PI3K/Akt/mTOR inhibitors in breast cancer[J];Cancer Biology & Medicine;2015年04期
8 沈艷;管曉翔;;三陰性乳腺癌靶向VEGF的治療策略[J];癌癥進展;2015年05期
9 尉承澤;郝曉鵬;;三陰性乳腺癌分子特征與潛在治療靶點[J];中國實用外科雜志;2015年07期
10 鄭紅梅;原俊;吳新紅;;三陰性乳腺癌的分子學分類和靶向治療[J];腫瘤防治研究;2015年02期
相關(guān)博士學位論文 前2條
1 李冬;防己諾林堿的蛋白酶體抑制作用在其抗腫瘤作用中的機制研究[D];長春中醫(yī)藥大學;2014年
2 王增四;小檗堿促進胰島素分泌改善胰島素抵抗的分子機制[D];華中科技大學;2009年
相關(guān)碩士學位論文 前1條
1 李凌帆;三陰性乳腺癌潛在內(nèi)分泌治療靶點的研究現(xiàn)狀[D];重慶醫(yī)科大學;2015年
,本文編號:2324498
本文鏈接:http://sikaile.net/yixuelunwen/zlx/2324498.html